Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance
- PMID: 11036052
- PMCID: PMC101632
- DOI: 10.1128/AAC.44.11.3196-3198.2000
Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance
Abstract
A strain of Streptococcus pyogenes resistant to multiple fluoroquinolones was isolated from the blood of an immunocompromised patient. Resistance to fluoroquinolones in S. pyogenes has not been previously studied. Compared to 10 sensitive strains of S. pyogenes, the fluoroquinolone-resistant clinical isolate of S. pyogenes presented point mutations in gyrA, predicting that serine-81 was changed to phenylalanine and that methionine-99 was changed to leucine, and in parC, predicting that serine-79 was changed to tyrosine. The mechanism of fluoroquinolone resistance in this isolate of S. pyogenes appears to be analogous to previously reported mechanisms for Streptococcus pneumoniae.
Figures

Similar articles
-
Primary targets of fluoroquinolones in Streptococcus pneumoniae.Antimicrob Agents Chemother. 1999 Feb;43(2):410-2. doi: 10.1128/AAC.43.2.410. Antimicrob Agents Chemother. 1999. PMID: 9925547 Free PMC article.
-
Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.J Antimicrob Chemother. 2000 Jun;45(6):771-5. doi: 10.1093/jac/45.6.771. J Antimicrob Chemother. 2000. PMID: 10837428
-
In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.J Antimicrob Chemother. 2007 Jan;59(1):28-34. doi: 10.1093/jac/dkl428. Epub 2006 Oct 25. J Antimicrob Chemother. 2007. PMID: 17065188
-
High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.Clin Microbiol Infect. 2004 Jul;10(7):659-62. doi: 10.1111/j.1469-0691.2004.00890.x. Clin Microbiol Infect. 2004. PMID: 15214881
-
Mechanisms of Streptococcus pyogenes Antibiotic Resistance.2022 Sep 19 [updated 2022 Oct 9]. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. 2nd edition. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2022 Oct 8. Chapter 30. 2022 Sep 19 [updated 2022 Oct 9]. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. 2nd edition. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2022 Oct 8. Chapter 30. PMID: 36479762 Free Books & Documents. Review. No abstract available.
Cited by
-
Molecular characterization of acquired enrofloxacin resistance in Mycoplasma synoviae field isolates.Antimicrob Agents Chemother. 2013 Jul;57(7):3072-7. doi: 10.1128/AAC.00203-13. Epub 2013 Apr 22. Antimicrob Agents Chemother. 2013. PMID: 23612192 Free PMC article.
-
Global fluoroquinolone resistance epidemiology and implictions for clinical use.Interdiscip Perspect Infect Dis. 2012;2012:976273. doi: 10.1155/2012/976273. Epub 2012 Oct 14. Interdiscip Perspect Infect Dis. 2012. PMID: 23097666 Free PMC article.
-
Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones.Antimicrob Agents Chemother. 2005 May;49(5):2130-2. doi: 10.1128/AAC.49.5.2130-2132.2005. Antimicrob Agents Chemother. 2005. PMID: 15855546 Free PMC article.
-
Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity.Antimicrob Agents Chemother. 2005 Jan;49(1):418-20. doi: 10.1128/AAC.49.1.418-420.2005. Antimicrob Agents Chemother. 2005. PMID: 15616324 Free PMC article.
-
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.Antimicrob Agents Chemother. 2010 Jun;54(6):2677-80. doi: 10.1128/AAC.01536-09. Epub 2010 Mar 29. Antimicrob Agents Chemother. 2010. PMID: 20350943 Free PMC article.
References
-
- Blondeau J M. A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones. J Antimicrob Chemother. 1999;43(Suppl. B):1–11. - PubMed
-
- Chen D K, McGeer A, de Azavedo J C, Low E E the Canadian Bacterial Surveillance Network. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med. 1999;341:233–239. - PubMed
-
- Drlica K. Mechanism of fluoroquinolone action. Curr Opin Microbiol. 1999;2:504–508. - PubMed
-
- Ferraro M J, Craig W A, Dudley M N, Eliopoulos G, Hecht D W, Hindler J, Reller L B, Sheldon A T, Swenson J M, Tenover F C, Testa R T, Weinstein M P, Wikler M A. NCCLS (ed.), Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 5th ed. M7-A5 and M100-S10. Wayne, Pa: NCCLS; 2000.
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Molecular Biology Databases